BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17596256)

  • 21. Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment.
    Mugittu K; Priotto G; Guthmann JP; Kiguli J; Adjuik M; Snounou G; Beck HP; Mshinda H; Olliaro PL; Taylor WR
    Trop Med Int Health; 2007 Feb; 12(2):219-23. PubMed ID: 17300628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria.
    Happi CT; Gbotosho GO; Sowunmi A; Falade CO; Akinboye DO; Gerena L; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Am J Trop Med Hyg; 2004 Jan; 70(1):20-6. PubMed ID: 14971693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short report: Dynamics of Plasmodium falciparum malaria after sub-optimal therapy in Uganda.
    Myrick A; Leemann E; Dokomajilar C; Hopkins H; Dorsey G; Kamya MR; Rosenthal PJ
    Am J Trop Med Hyg; 2006 May; 74(5):758-61. PubMed ID: 16687676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women.
    Tukur IU; Thacher TD; Sagay AS; Madaki JK
    Am J Trop Med Hyg; 2007 Jun; 76(6):1019-23. PubMed ID: 17556604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continued efficacy of sulfadoxine-pyrimethamine as second line treatment for malaria in children in Guinea-Bissau.
    Kofoed PE; Rodrigues A; Aaby P; Rombo L
    Acta Trop; 2006 Dec; 100(3):213-7. PubMed ID: 17173847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.
    Bakyaita N; Dorsey G; Yeka A; Banek K; Staedke SG; Kamya MR; Talisuna A; Kironde F; Nsobya S; Kilian A; Reingold A; Rosenthal PJ; Wabwire-Mangen F
    Am J Trop Med Hyg; 2005 May; 72(5):573-80. PubMed ID: 15891132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad.
    Grandesso F; Bachy C; Donam I; Ntambi J; Habimana J; D'Alessandro U; Maikere J; Vanlerberghe V; Kerah CH; Guthmann JP
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):419-26. PubMed ID: 16297419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
    Ezedinachi EN; Ekanem OJ; Chukwuani CM; Meremikwu MM; Ojar EA; Alaribe AA; Umotong AB; Haller L
    Am J Trop Med Hyg; 1999 Jul; 61(1):114-9. PubMed ID: 10432067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring efficacy of commonly used antimalarials by a 14-day in-vivo test in a new settler's camp in endemic zone at Cox's Bazar.
    Rahman MR; Hassan MR; Faiz MA; Samad R; Paul B; Jalil MA
    Bangladesh Med Res Counc Bull; 1998 Dec; 24(3):67-74. PubMed ID: 10874370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998.
    MacArthur J; Stennies GM; Macheso A; Kolczak MS; Green MD; Ali D; Barat LM; Kazembe PN; Ruebush TK
    Am J Trop Med Hyg; 2001 Dec; 65(6):679-84. PubMed ID: 11791956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the therapeutic efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum malaria in a tribal block of the Kalahandi district of Orissa, India.
    Kerketta AS; Mohapatra SS; Kar SK
    Trop Doct; 2008 Apr; 38(2):82-4. PubMed ID: 18453492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short report: comparison of chlorproguanil-dapsone with a combination of sulfadoxine-pyrimethamine and chloroquine in children with malaria in northcentral Nigeria.
    Ogunfowokan O; Dankyau M; Madaki AJ; Thacher TD
    Am J Trop Med Hyg; 2009 Feb; 80(2):199-201. PubMed ID: 19190213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis.
    A-Elbasit IE; Elbashir MI; Khalil IF; Alifrangis M; Giha HA
    Trop Med Int Health; 2006 May; 11(5):604-12. PubMed ID: 16640612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates.
    Henry M; Diallo I; Bordes J; Ka S; Pradines B; Diatta B; M'Baye PS; Sane M; Thiam M; Gueye PM; Wade B; Touze JE; Debonne JM; Rogier C; Fusai T
    Am J Trop Med Hyg; 2006 Jul; 75(1):146-51. PubMed ID: 16837722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness.
    Mugittu K; Adjuik M; Snounou G; Ntoumi F; Taylor W; Mshinda H; Olliaro P; Beck HP
    Trop Med Int Health; 2006 Sep; 11(9):1350-9. PubMed ID: 16930256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic efficacy of chloroquine or amodiaquine in combination with sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Papua New Guinea.
    Jayatilaka KD; Taviri J; Kemiki A; Hwaihwanje I; Bulungol P
    P N G Med J; 2003; 46(3-4):125-34. PubMed ID: 16454394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change.
    Basco LK; Ngane VF; Ndounga M; Same-Ekobo A; Youmba JC; Abodo RT; Soula G
    Am J Trop Med Hyg; 2006 Sep; 75(3):388-95. PubMed ID: 16968911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children.
    Ekanem OJ; Weisfeld JS; Salako LA; Nahlen BL; Ezedinachi EN; Walker O; Breman JG; Laoye OJ; Hedberg K
    Bull World Health Organ; 1990; 68(1):45-52. PubMed ID: 2189585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.